LENZ THERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
LENZ THERAPEUTICS, INC. (LENZ) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.53 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11
- LENZ THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 5.14M shares, a 31.11% increase year-over-year.
- LENZ THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 3.92M shares, a 14.17% increase year-over-year.
- LENZ THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 3.43M shares, a 72.74% decline year-over-year.
- LENZ THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-09-30 was 7.26M shares, a 35.23% decline year-over-year.
- LENZ THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 4.02M shares, a 27.32% increase from fiscal 2024.
- LENZ THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 3.16M shares, a 76.45% decline from fiscal 2023.
- LENZ THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 13.40M shares, a 25.38% increase from fiscal 2022.
- LENZ THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 10.69M shares, a 99.89% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.53M shares 10-Q · filed 2026-08-11 | |||||||
| 2026-03-31 | 5.14M shares 10-Q · filed 2026-05-11 | |||||||
| 2025-12-31 | 4.02M shares 10-K · filed 2026-03-24 | |||||||
| 2025-09-30 | 4.03M shares 10-Q · filed 2025-11-05 | |||||||
| 2025-06-30 | 4.09M shares 10-Q · filed 2026-08-11 | |||||||
| 2025-03-31 | 3.92M shares 10-Q · filed 2026-05-11 | |||||||
| 2024-12-31 | 3.16M shares 10-K · filed 2026-03-24 | |||||||
| 2024-09-30 | 3.10M shares 10-Q · filed 2025-11-05 | |||||||
| 2024-06-30 | 3.17M shares 10-Q · filed 2025-07-30 | |||||||
| 2024-03-31 | 3.43M shares 10-Q · filed 2025-05-07 | |||||||
| 2023-12-31 | 13.40M shares 10-K · filed 2025-03-19 | 5.94M shares 10-K · filed 2024-02-27 | ||||||
| 2023-09-30 | 7.26M shares 10-Q · filed 2023-11-13 | 13.40M shares 10-Q · filed 2024-11-06 | 7.26M shares 10-Q · filed 2023-11-13 | |||||
| 2023-06-30 | 10.58M shares 10-Q · filed 2023-08-14 | 13.36M shares 10-Q · filed 2024-08-14 | 10.58M shares 10-Q · filed 2023-08-14 | |||||
| 2023-03-31 | 12.59M shares 10-Q · filed 2024-05-08 | 12.23M shares 10-Q · filed 2023-05-11 | ||||||
| 2022-12-31 | 10.69M shares 10-K · filed 2024-02-27 | 10.69B shares 10-K · filed 2023-03-20 | ||||||
| 2022-09-30 | 11.21M shares 10-Q · filed 2023-11-13 | 11.21M shares 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | 11.58M shares 10-Q · filed 2023-08-14 | 11.58M shares 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | 11.39M shares 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | 9.93B shares 10-K · filed 2023-03-20 | |||||||
| 2021-09-30 | 10.55M shares 10-Q · filed 2022-11-09 | 10.55M shares 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | 10.34M shares 10-Q · filed 2022-08-11 | 10.34M shares 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | 39.04M shares 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | 18.65B shares 10-K · filed 2022-03-21 | |||||||
| 2020-09-30 | 21.55M shares 10-Q · filed 2021-11-10 | 21.55M shares 10-Q · filed 2021-11-10 | ||||||
| 2020-06-30 | 21.02M shares 10-Q · filed 2021-08-12 | 21.02M shares 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |